Ever heard of the phrase, “Don’t go to sleep angry?” For those who have been alive during the past century or so, chances are high that this is the case. If so, a recent study shows that there is a good reason why this advice has been around for a long time. It’s a good one.
Sleeping angry is something that a lot of people have had to do for numerous reason. Some examples include a fight with one’s spouse, disagreement with parents or family members, or just seeing a favorite character die in Game of Thrones. Whatever the case, researchers from the Beijing Normal University encourage finding ways to get rid of the feeling before going to sleep, The Guardian reports.
Yunzhe Liu led the study which enlisted the participation of 73 subjects, all of whom were healthy males and were in college. The participants were shown a series of images, many of which were disturbing. They were then asked to either recall certain images or forget about them.
The experiment lasted for two days. During that time, the participants were tested twice. Once after just 30 minutes of being shown the disturbing images. Then another time after getting a good night’s sleep.
Based on the results, it’s much more difficult to forget about certain memories that carried negative emotions once the subjects slept on it, compared to when they were asked to do so a half hour after being shown said images. This means that if someone were to go to sleep angry, they would be more likely to stay angry or to carry around the negative emotion for longer, MedicalXpress reports.
With regards to benefits from the research, other than forcing couples to reconcile before bedtime, advancing treatments of PTSD patients is a potential target. However, the researchers caution that since the participants during the test were of healthy minds, there is no guarantee that people with psychological issues would even gain anything from the results of the study.


NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
Why the future of marijuana legalization remains hazy despite high public support
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
The four types of dementia most people don’t know exist
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 



